GFAP and Alzheimer disease: A‐T‐N‐ MCI patients who are classified as controls compared with AD, DLB, and FTD patients for pTau217, Aβ42, NfL, and GFAP and further enhanced the differentiation except for Aβ42 (Supplementary Material 1)